August 21, 2023

Criteria and Risks of Using Viagra in Dosages of 150mg and 200mg

November 10, 2011

Aquinox Pharmaceuticals Initiates Two Phase IIa Clinical Studies in Airway Inflammation Following Successful Phase I

January 5, 2011

Aquinox Pharmaceuticals Receives Regulatory Clearance to Initiate First Clinical Study of AQX-1125, A Novel Oral Anti-Inflammatory Compound

September 15, 2010

Aquinox Pharmaceuticals appoints Csaba Szabó, M.D., Ph.D., Vice President, Research and Chief Scientific Officer

June 17, 2010

Aquinox Pharmaceuticals completes US $25 million Series B financing

October 11, 2009

Aquinox Pharmaceuticals Selects AQX-1125 as Lead Clinical Candidate

July 10, 2008

Aquinox Pharmaceuticals Inc. Names Board Member

September 14, 2007

With help from Mother Nature: A Novel New Drug Discovery May Revolutionize Treatment of Inflammatory Diseases and Leukemia

June 12, 2007

Aquinox Pharmaceuticals Inc. Completes US$14.5 million Series A financing